Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 264

Results For "ENT"

10702 News Found

71% of Indians targeted by health scams amid rise of AI-generated misinformation: McAfee study
Healthcare | June 23, 2026

71% of Indians targeted by health scams amid rise of AI-generated misinformation: McAfee study

Social media emerges as the primary channel for health-related scams, while influencer endorsements and AI-generated content amplify risks for consumers


Pfizer lung cancer drug misses key survival goal in Phase 3 trial
Clinical Trials | June 23, 2026

Pfizer lung cancer drug misses key survival goal in Phase 3 trial

The company said the safety profile remained consistent with earlier studies and was considered manageable


Girls with ADHD from deprived backgrounds face sharply higher risk of long-term health conditions: Study
Healthcare | June 23, 2026

Girls with ADHD from deprived backgrounds face sharply higher risk of long-term health conditions: Study

The research underscores growing concern that the intersection of neurodevelopmental conditions and social disadvantage can significantly compound health risks across the life course


AbbVie to acquire Apogee in $10.9 billion immunology power play
Biopharma | June 23, 2026

AbbVie to acquire Apogee in $10.9 billion immunology power play

Under the agreement, Apogee shareholders will receive $135.11 per share in cash, and the transaction has been unanimously approved by both companies’ boards


Suven Life Sciences to spotlight CNS pipeline & strike partnering deals at BIO-2026 San Diego
Biotech | June 23, 2026

Suven Life Sciences to spotlight CNS pipeline & strike partnering deals at BIO-2026 San Diego

The company plans an aggressive partnering push, with 62 pre-scheduled meetings over four days, focused on out-licensing, co-development, and strategic collaborations with global pharmaceutical and biotech players


FDA fast-tracks Roche cancer drug filing after landmark trial shows 50% recurrence reduction
Drug Approval | June 23, 2026

FDA fast-tracks Roche cancer drug filing after landmark trial shows 50% recurrence reduction

The FDA has granted Priority Review, setting a target decision date of 9 October 2026, potentially accelerating access to a new treatment option for a subset of patients with high-risk colon cancer characterized


AbbVie unveils 9-Yr CLL data showing lasting survival benefit for Venetoclax-based therapy
Biopharma | June 23, 2026

AbbVie unveils 9-Yr CLL data showing lasting survival benefit for Venetoclax-based therapy

Researchers emphasized that the benefit persisted well beyond the treatment period, reinforcing the clinical rationale for time-limited therapy in selected patients


KIMS Hospitals launches RENOVA Oncology Institute in Bengaluru
Hospitals | June 23, 2026

KIMS Hospitals launches RENOVA Oncology Institute in Bengaluru

KIMS RENOVA Oncology Institute, in association with the Samrohana Cancer Foundation, announced the “134 Free Screening Camp Pledge”,


ZEISS and Envision Health Technologies team up to push VR-based glaucoma testing forward
Technology | June 23, 2026

ZEISS and Envision Health Technologies team up to push VR-based glaucoma testing forward

The move comes as demand rises for wider access to glaucoma screening and more flexible clinical workflows


HCG launches breast Cancer Care Clinic in Bengaluru
Healthcare | June 23, 2026

HCG launches breast Cancer Care Clinic in Bengaluru

About 250+ women riders participate in the awareness ride where free breast screening camp were conducted